[HTML][HTML] Molnupiravir Use Among Patients with COVID-19 in Real-World Settings: A Systematic Literature Review
J Richmond DiBello, VT Raziano, X Liu… - Infectious Diseases and …, 2024 - Springer
Introduction Molnupiravir (MOV) is an oral antiviral for the treatment of individuals with mild-
to-moderate COVID-19 and at high risk of progression to severe disease. Our objective was …
to-moderate COVID-19 and at high risk of progression to severe disease. Our objective was …
[PDF][PDF] Molnupiravir Use Among Patients with COVID‑19 in Real‑World Settings: A Systematic Literature
JR DiBello, VT Raziano, X Liu, A Puenpatom… - scienceopen.com
Introduction: Molnupiravir (MOV) is an oral antiviral for the treatment of individuals with mild-
to-moderate COVID-19 and at high risk of progression to severe disease. Our objective was …
to-moderate COVID-19 and at high risk of progression to severe disease. Our objective was …
Molnupiravir Use Among Patients with COVID-19 in Real-World Settings: A Systematic Literature Review.
J Richmond DiBello, VT Raziano… - … Diseases & Therapy, 2024 - search.ebscohost.com
Introduction: Molnupiravir (MOV) is an oral antiviral for the treatment of individuals with mild-
to-moderate COVID-19 and at high risk of progression to severe disease. Our objective was …
to-moderate COVID-19 and at high risk of progression to severe disease. Our objective was …
[HTML][HTML] Molnupiravir Use Among Patients with COVID-19 in Real-World Settings: A Systematic Literature Review
JR DiBello, VT Raziano, X Liu… - Infectious Diseases …, 2024 - ncbi.nlm.nih.gov
Methods The SLR was conducted in accordance with the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses 2020 guidelines and using pre-determined …
Systematic Reviews and Meta-Analyses 2020 guidelines and using pre-determined …
Molnupiravir Use Among Patients with COVID-19 in Real-World Settings: A Systematic Literature Review
JR DiBello, VT Raziano, X Liu… - Infectious diseases … - pubmed.ncbi.nlm.nih.gov
Introduction Molnupiravir (MOV) is an oral antiviral for the treatment of individuals with mild-
to-moderate COVID-19 and at high risk of progression to severe disease. Our objective was …
to-moderate COVID-19 and at high risk of progression to severe disease. Our objective was …
Molnupiravir Use Among Patients with COVID-19 in Real-World Settings: A Systematic Literature Review.
VT Raziano, X Liu, A Puenpatom… - Infectious Diseases …, 2024 - europepmc.org
Methods The SLR was conducted in accordance with the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses 2020 guidelines and using pre-determined …
Systematic Reviews and Meta-Analyses 2020 guidelines and using pre-determined …